OverviewSuggest Edit

Royal DSM is a science-based company engaged in nutrition, health, and sustainable living. The company delivers business solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. It operates through three segments: Nutrition, Materials, and Innovation Center. The Nutrition segment offers nutrients, such as vitamins, carotenoids, nutritional lipids, and other ingredients to feed, food, pharmaceutical, and personal care industries. The Materials segment provides fiber solutions, high-performance plastics, resins solutions. The Innovation Center segment offers cellulosic bio-ethanol and bio-based succinic acids, anti-reflective coatings for solar glass, and anti-soiling coatings, as well as biomedical materials and technologies.
TypePublic
Founded1902
HQHeerlen, NL
Websitedsm.com
Employee Ratings3.5

Latest Updates

Employees (est.) (Sep 2019)22,204(+3%)
Job Openings142
Revenue (FY, 2018)€9.3 B(+8%)
Share Price (Sep 2018)$7.5

Key People/Management at Royal DSM

Feike Sijbesma

Feike Sijbesma

CEO & Chairman
Geraldine Matchett

Geraldine Matchett

CFO and Member of the Managing Board
Marcus Remmers

Marcus Remmers

CTO
Maha Elkharbotly

Maha Elkharbotly

Global Chief Marketing Officer
Peter Dew

Peter Dew

Chief Digital Officer
Fidelis Fru

Fidelis Fru

Vice President- Europe, Middle East and Africa, Animal Nutrition and Health
Show more

Royal DSM Office Locations

Royal DSM has offices in Heerlen, Amsterdam, Delft, Emmen and in 148 other locations
Heerlen, NL (HQ)
1 Het Overloon
Amsterdam, NL
Strawinskylaan 1
Delft, NL
1 Alexander Fleminglaan
Delft, NL
Turbineweg 10
Emmen, NL
Eerste Bokslootweg 17
Geleen, NL
Koestraat 1
Show all (182)

Royal DSM Financials and Metrics

Royal DSM Revenue

Embed Graph
View revenue for all periods
Royal DSM's revenue was reported to be €9.27 b in FY, 2018 which is a 7.4% increase from the previous period.
EUR

Revenue (Q3, 2019)

2.3b

Net income (Q3, 2019)

239.0m

EBITDA (Q3, 2019)

416.0m

EBIT (Q3, 2019)

266.0m

Market capitalization (12-Sep-2018)

371.3m

Closing stock price (12-Sep-2018)

7.5

Cash (30-Sep-2019)

926.0m

EV

2.0b
Royal DSM's current market capitalization is $371.3 m.
Annual
EURFY, 2016FY, 2017FY, 2018

Revenue

7.9b8.6b9.3b

Revenue growth, %

(11%)9%7%

Cost of goods sold

5.3b5.7b5.9b

Gross profit

2.7b2.9b3.4b
Quarterly
Annual
EURFY, 2016FY, 2017FY, 2018

Cash

604.0m899.0m1.3b

Accounts Receivable

1.5b1.5b1.6b

Inventories

1.8b1.8b2.0b

Current Assets

5.0b5.4b6.3b
Quarterly
EURQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

574.0m369.0m1.6b1.1b813.0m997.0m1.0b1.1b926.0m

Accounts Receivable

1.6b1.6b1.6b1.8b1.8b1.7b1.8b1.7b1.7b

Inventories

1.9b1.9b1.8b1.9b2.0b2.0b2.1b2.1b2.1b

Current Assets

5.2b5.2b6.3b6.0b5.8b5.9b6.6b6.3b5.8b
Annual
EURFY, 2016FY, 2017FY, 2018

Net Income

629.0m1.8b1.1b

Depreciation and Amortization

489.0m502.0m509.0m

Inventories

(138.0m)(201.0m)(166.0m)

Accounts Payable

195.0m127.0m(6.0m)
Quarterly
EURQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash From Operating Activities

196.0m329.0m619.0m310.0m503.0m933.0m201.0m507.0m941.0m

Cash From Investing Activities

(194.0m)(268.0m)906.0m(143.0m)(364.0m)(505.0m)(474.0m)(331.0m)(364.0m)

Long-term Borrowings

(4.0m)(25.0m)(12.0m)(57.0m)(340.0m)

Dividends Paid

(135.0m)(199.0m)(139.0m)(223.0m)(158.0m)(277.0m)
EURY, 2019

EV/EBITDA

4.9 x

EV/EBIT

7.6 x

EV/CFO

2.2 x

EV/FCF

3.9 x

Revenue/Employee

103.1k

Debt/Equity

0.3 x

Debt/Assets

0.2 x

Financial Leverage

1.7 x
Show all financial metrics

Royal DSM Operating Metrics

FY, 2016FY, 2017FY, 2018

Countries (Facilities)

40 40 40

Manufacturing Facilities

100 100 110

Patent Applications Filed Yearly

220 282 397

Suppliers

40 k34 k35 k
Show all operating metrics

Royal DSM Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
SRF LimitedMay 13, 2019₹3.20 b
Amyris Brasil Pesquisa e DesenvolvimentoDecember 29, 2017
Biocare Copenhagen ApSDecember 22, 2017
TwilmijSeptember 22, 2017
Suzhou Sunshine New Materials Technology Co LtdFebruary 16, 2017
Cubic Tech CorpMay 13, 2015
Aland (Jiangsu) NutraceuticalMarch 31, 2015
Bayer - Animal Health Premix BusinessJuly 02, 2013
Unitech Industries LtdJune 28, 2013
FortitechDecember 18, 2012$634 m
Show more

Royal DSM Revenue Breakdown

Embed Graph

Royal DSM revenue breakdown by business segment: 31.4% from Materials, 66.2% from Nutrition and 2.3% from Other

Royal DSM revenue breakdown by geographic segment: 9.8% from Rest of Asia, 12.2% from China, 11.7% from Latin America, 6.4% from Eastern Europe, 22.3% from North America, 24.1% from Rest of Western Europe and 13.5% from Other

Human Capital Metrics

Royal DSM's employees are reported to be approximately 28% female and 72% male.
Embed Graph
Show all human capital metrics

Royal DSM Online and Social Media Presence

Embed Graph

Royal DSM News and Updates

Global Powder Coatings Market 2019-2024 - Major Players are Akzo Nobel N.V., BASF SE, Sherwin Williams, PPG Industries, Lonza Group, and Royal DSM

DUBLIN, July 22, 2019 /PRNewswire/ -- The "Powder Coatings Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. The powder coatings market is expected to grow at a CAGR of above 6% during the forecast period of 2019-2024 Major...

Nutraceutical Ingredients Market Outlook, 2025 Featuring Royal DSM, DuPont, Cargill, ADM, BASF, Omega Protein Corp

DUBLIN, July 12, 2019 /PRNewswire/ -- The "Global Nutraceutical Ingredients Market by Type, by Products, by Region - Market Outlook 2025" report has been added to ResearchAndMarkets.com's offering. Global nutraceutical market has witnessed a slowdown in mergers and acquisition activities...

Royal DSM Boosts 2019 Outlook

Royal DSM Boosts 2019 Outlook

Informative Report on Medical Device Coatings Market 209 | Key Players like Surmodics, Inc., Covalon Technologies Ltd., Royal DSM, Hydromer. Inc., Precision Coatings Co. Inc., AST Products Inc.

Medical coatings range from lubrications to anti-microbial liquids to water repellent polymers, and each variety of coating is used on a multitude of devices for many different applications. Medical equipment is used at every phase of procedure, from basic check-ups, as well to surgeries and clinica…

Royal DSM opens new animal nutrition plant in Telangana

: The Netherlands-based multi-national firm Royal DSM opened its second animal nutrition and health pre-mix plant at Jadcherla in Telangana Monday. The plant was inaugurated after years of research and analysis of the Indian market with an aim at serving it with solutions tailor-made for local …

Nylon 6/6 2018 Global Market Key Players - Ube Industries, Radici Group, BASF, Royal DSM, Evonik Industries, Lanxess, SABIC, Asahi Kasei Corporation-Analysis And Forecast To 2023

Nylon 6/6 – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2023 Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more

Royal DSM Frequently Asked Questions

  • When was Royal DSM founded?

    Royal DSM was founded in 1902.

  • Who are Royal DSM key executives?

    Royal DSM's key executives are Feike Sijbesma, Geraldine Matchett and Marcus Remmers.

  • How many employees does Royal DSM have?

    Royal DSM has 22,204 employees.

  • What is Royal DSM revenue?

    Latest Royal DSM annual revenue is €9.3 b.

  • What is Royal DSM revenue per employee?

    Latest Royal DSM revenue per employee is €417.4 k.

  • Who are Royal DSM competitors?

    Competitors of Royal DSM include Lonza, Eastman and AkzoNobel.

  • Where is Royal DSM headquarters?

    Royal DSM headquarters is located at 1 Het Overloon, Heerlen.

  • Where are Royal DSM offices?

    Royal DSM has offices in Heerlen, Amsterdam, Delft, Emmen and in 148 other locations.

  • How many offices does Royal DSM have?

    Royal DSM has 182 offices.